Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Intermittent Claudication

• BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers
• A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)
• BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
• A Randomized Clinical Trial for GNX80 in Intermittent Claudication
• Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
• MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
• Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
• The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
• Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
• VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.
• Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
• Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
• Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
• Red Light Treatment in Peripheral Artery Disease
• Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
• Efficacy of Sildenafil on the Morbi-mortality of Peripheral Arterial Diseased Patients With Intermittent Claudication
• Ramipril Treatment of Claudication
• Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
• Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
• Cilostazol After Lower Extremity Arterial Revascularization Trial
• Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)
• Randomized Phase IIb Trial of DVC1-0101
• The Effects of Fish Oil Supplements During Supervised Exercise Therapy in Patients With Intermittent Claudication
• Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
• The MiDAS ENCORE Study
• Bilateral Transforaminal Epidural Steroid Injections for Degenerative Lumbar Spinal Stenosis
• Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication
• A Study to Evaluate Efficacy of 『Opast Tablet』for Neurologic Claudication in Patients With Lumbar Spinal Stenosis
• The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
• Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease
• Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
• Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.
• Prostaglandin E1 in Outpatients With Intermittent Claudication
• Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
• Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication
• A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
• Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
• Evaluation of Cilostazol in Combination With L-Carnitine
• Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
• A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions
• Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication
• Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions
• Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions
• Imaging of Totally Blocked Arteries
• Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease
• FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
• A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
• Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
• Caffeine and Intermittent Claudication
• Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease
• Mixed Antagonist of Serotonin for Claudication Optimal Therapy
• Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
• ARREST PAD (Peripheral Arterial Disease)
• Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
• Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication
• EW-A-401 to Treat Intermittent Claudication
• The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
• Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
• Extract of Ginkgo Biloba (EGB 761) and Vascular Function